Changes in concentration of reduced and oxidized IOWMr thiols were measured in blood and plasma before and after the separation of blood cells. If centrifugation of blood was postponed, the reduced form of homocysteine in plasma increased with time at 22#{176}C; in contrast, the concentrations of other reduced thiols (cysteine, glutathione, and cysteinyiglycine) decreased. In plasma the reduced forms of all thiols disappeared at a rate that followed first-order kinetics. The rates of disappearance ("half-lives") were temperature-dependent; they were about the same for glutathione and homocysteine (11.7 and 14.3 mm, respectively, at 22#{176}C) and somewhat higher for cysteinyiglycine and cysteine. After establishing proper sampling conditions for reduced thiols, we measured this thiol fraction as well as free (non-proteinbound) and total thiols in 10 reference subjects and 19 patients with cerebral infarction. Mild but significant hyperhomocysteinemia involving total and free homocysteine (but not reduced homocysteine) was found in the patients. 
Methods and Subjects

Nomenclature.
Human plasma contains several different homocysteine derivatives, and the term "homocysteine" is often used in contexts that include several of these derivatives.
We therefore use the term "reduced homocysteine" or reduced thiol when referring to the fraction of homocysteine or thiol in plasma, which is exclusively in its sulthydryl form. free, and free oxidized thiols in plasma was studied in the following experiment:
Blood was drawn from four subjects into prechilled (in ice-water) EDTAVacutainer#{174} Tubes (Becton Dickinson, Rutherford, NJ), which were placed without delay (within 10 s) in ice-water and chilled for 6 mm (zero reference time) before storage at 4#{176}C. Part of the blood (2 mL) was transferred to an Eppendorf tube after 0, 60, and 85 mm and then centrifuged at 10 000g at 4#{176}C for 2.5 mm. Plasma (0.9 mL) was immediately mixed with sulfosalicylic acid (150 gfL, 0.225 mL). After mixing, the precipitate was kept at 4#{176}C for 30 mm before freezing at -70#{176}C. Free and reduced thiols were assayed within 1 day. Blood from the same four subjects was also drawn into a second prechilled (in ice-water) EDTA-Vacutamer Tube, agitated, and then placed in temperature (22#{176}C) water (zero reference time) and further processed as described for the 4#{176}C samples.
Effect of delayed protein precipitation.
The disappearance of reduced thiols from plasma by autoxidation was studied in the following experiment: Blood from four subjects was collected into EDTA-Vacutainer Tubes, chilled to 4 or 22#{176}C, and then divided into six samples (1.0 mL in 1.5-mL Eppendorf tubes), which were centrifuged at 4 or 22#{176}C at 10 000g for 2.5 mm (including acceleration and retardation). After 0, 4, 12, 26, 56, and 120 mm 400 L of plasma was transferred to tubes containing 0.1 mL of 150 gIL sulfosalicylic acid, mixed, and kept at 4#{176}C for 30 mm before freezing at -70#{176}C. Within 1 day the tubes were thawed and centrifuged (10 000g, 4#{176}C, 3 mm), and the plasma samples were analyzed for reduced thiols, as described earlier (10). Time(minutes) Fig. 1 . Effect of postponement (at 22#{176}C) of protein precipitation on the concentrations of reduced thiols in plasma from one subject. Concentrations are expressed relative to the concentrations at zero-time (= 100%), which in this subject were: homocysteine, 0.21; cysteine, 9.8; glutathione, 4.5; and cysteinylglycine, 2.9 moVL The time-dependence of the concentration of reduced thiols in this subject was typical for all subjects. (Table 2) .
Clinical Findings
Patients with cerebral infarction.
Total and free homocysteine concentrations were significantly greater in the patients than in the reference subjects; that of reduced homocysteine was not (Table 3) . Total plasma cysteine showed a slight significant increase in the patients, whereas reduced and free plasma cysteine showed normal concentrations.
Neither total, free, nor reduced forms of cysteinylglycine were different in plasma from patients vs reference subjects (Table 3 ). The correlation between free and total plasma homocysteine was strong in both groups: r = 0.78 and 0.96 (both P <0.001), respectively. In plasma from the patients, reduced homocysteine was correlated with free homocysteine (r = 0.47, P = 0.004) but not with total plasma homocysteine (r = 0.4, P = 0.09). In plasma from the reference subjects, reduced homocysteine correlated with both free (r = 0.8, P = 0.04) and total homocysteine (r = 0.87, P = 0.02). In the patients, total homocysteine correlated with total cysteine (r = 0.57) but not with total cysteinyiglycine.
Free homocystome correlated with free cysteine (r = 0.68, P <0.001) The fraction of reduced/total homocysteine (Table 3) showed a tendency (not significant) to be lower in the patients with cerebral infarction (0.013) than in the reference subjects (0.015). The same relation was applicable to cysteine and cysteinylglycine.
Patient with homocystinuria.
The main findings in this patient were increased concentrations of all forms of homocysteine and a decrease in total and free plasma cysteine.
Total plasma cysteinylglycine was also somewhat decreased, whereas the other forms showed normal concentrations (Table 3 ). The ratio between the concentrations of reduced and total aminothiols was greater in the patients than in the reference subjects (Table 3) .
Discussion
Export from erythrocytes.
We previously reported (21) that the total concentrations of glutathione, cysteinyiglycine, and homocysteine in plasma increased with time if the centrifugation of EDTA-treated blood was postponed.
Whole blood anticoagulated with heparm showed similarresults (26), as we also have noted (unpublished data). We also found an increase in free homocysteine (non-protein-bound) that, during the first hour, was nearly the same as the increase in total homocysteine. The increase of homocysteine is the result of a continuous, temperature-dependent production of homocysteine in the erythrocytes (21, 26), followed by an export to the plasma.
In the present study we also measured the concentration of the reduced thiols, and calculated the concentration of free oxidized thiols in plasma (free oxidized thiols = free thiols minus reduced thiols). We confirmed the previous findings of an increase with time of free homocysteine at both 4#{176}C and 22#{176}C. We also showed that the increase in free homocysteine is mainly due to an increase in free oxidized homocysteine and is not affected to any significant extent by the increase (at 22#{176}C) or the decrease (at 4#{176}C) of reduced homocysteine. This is in contrast to the other free thiols. rapid decrease of reduced glutathione in plasma that was allowed to stand at 4#{176}C. The disappearance reported by Velury and Howell (25) of reduced glutathione added to plasma was slower than that reported by the other investigators.
The former found (25) that the half-lives of added reduced homocystemne ranged from 78 to 140 mm in various plasma samples.
The differences in half-lives between the investigated thiols in the present study ought to be reliable, given the precautions taken to allow the plasma to reach the desired temperature before the first sampling was done; we also calculated the half-lives from measurements at several different times. 
